지속적 신대체요법(CRRT) 소모품 시장 - 규모, 점유율, 성장 및 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of Continuous Renal Replacement Therapy (CRRT) consumables Market

The global Continuous Renal Replacement Therapy (CRRT) consumables market is witnessing steady growth due to the increasing prevalence of acute kidney injury (AKI), rising adoption of advanced renal care solutions, and expanding intensive care infrastructure worldwide. The market was valued at USD 912.56 million in 2025 and is projected to grow from USD 984.12 million in 2026 to USD 1,867.84 million by 2034, registering a CAGR of 8.34% during the forecast period (2026-2034).

In 2025, North America dominated the market with a 38.22% share, supported by strong healthcare infrastructure and growing awareness regarding advanced kidney replacement therapies.

CRRT consumables include essential medical products such as dialysates, replacement fluids, filters, anticoagulants, and catheters used during continuous renal replacement therapy. These products are critical in managing patients with severe kidney dysfunction, particularly those admitted to intensive care units (ICUs).

Market Dynamics

Market Drivers

Increasing Incidence of Acute Kidney Injury (AKI)

A significant rise in acute kidney injury cases globally is a key growth driver. According to clinical findings, millions of individuals suffer from AKI annually, with a high burden in low- and middle-income countries. Critically ill patients often require continuous renal replacement therapy rather than intermittent dialysis, thereby increasing demand for consumables such as hemofilters, dialysate fluids, and bloodline sets.

Additionally, growing product approvals and launches are boosting adoption. Technological advancements in CRRT machines and disposables are making therapy more efficient and accessible in ICUs.

Market Restraints

High Cost and Specialized Infrastructure Requirements

CRRT procedures are complex and require specialized ICU infrastructure and trained healthcare professionals. The recurring cost of consumables-including replacement fluids, dialysates, filters, and extracorporeal circuits-adds to the financial burden on healthcare facilities.

In developing economies, limited availability of skilled staff and high procedural costs restrict widespread adoption. A single CRRT session can cost several hundred dollars, limiting affordability in resource-constrained settings.

Market Opportunities

Shift Toward Value-Based Renal Care

Hospitals are increasingly adopting value-based care models focused on improving patient outcomes while optimizing ICU stays. This trend is generating demand for advanced, easy-to-use, and efficient CRRT consumables.

Manufacturers are introducing next-generation filters and fluid management systems designed to enhance toxin removal, minimize therapy interruptions, and simplify clinical workflows. Digital integration and training tools are also being implemented to improve healthcare professional expertise.

Market Challenges

Lack of Standardized Treatment Protocols

Unlike conventional dialysis, CRRT practices vary significantly across institutions in terms of dosing, modality selection, and fluid composition. This lack of global standardization complicates product design and slows regulatory approvals. It also makes outcome measurement and clinical trial standardization more challenging, potentially hindering broader adoption.

Market Trends

Technological Advancements and Digital Integration

The CRRT consumables market is benefiting from automation and digital health integration. Smart consumables with tracking capabilities allow real-time monitoring of therapy parameters and usage. Manufacturers are focusing on systems that simplify therapy delivery and improve safety.

Strategic partnerships between hospitals and suppliers for bulk procurement and subscription-based consumable supply models are also emerging as cost-control strategies.

Segmentation Analysis

By Type

• Replacement Solutions (Dominant Segment)

This segment holds the largest market share and is expected to maintain the highest CAGR. Replacement solutions are critical for maintaining fluid and electrolyte balance during CRRT. Increasing cases of sepsis-related AKI and multi-organ failure are driving demand.

• Dialysates (Second-Fastest Growing)
• Filters
• Catheters
• Others

The rising number of CRRT procedures globally is strengthening demand across all consumable categories.

By Modality

• Continuous Venovenous Hemodiafiltration (CVVHDF) - Largest Share

CVVHDF combines diffusion and convection mechanisms, offering comprehensive solute clearance. It is widely used for critically ill patients with complex metabolic imbalances.

• Continuous Venovenous Hemofiltration (CVVH) - Second Leading
• Continuous Venovenous Hemodialysis (CVVHD)
• Slow Continuous Ultrafiltration (SCUF)

CVVHDF remains the preferred modality due to its superior operational efficiency and clinical effectiveness.

Regional Outlook

North America

North America led the global market in 2025 with a 38.22% share. The regional market reached USD 330.72 million in 2026, supported by strong ICU infrastructure, favorable reimbursement policies, and growing awareness about renal care. Government initiatives and workforce development programs are further boosting regional growth.

Europe

Europe held a substantial share in 2024 and is expected to show steady growth through 2034. Strong research initiatives, an aging population, and increasing kidney disease prevalence are key growth contributors.

Asia Pacific

Asia Pacific is projected to register the highest CAGR during the forecast period. The rapidly aging population and increasing incidence of kidney disorders are expanding the demand for CRRT procedures in countries such as China and India.

Latin America & Middle East & Africa

Latin America is experiencing gradual growth due to increased investments in renal care. Meanwhile, the Middle East & Africa region is witnessing moderate expansion driven by improving ICU facilities and awareness regarding advanced renal therapies.

Competitive Landscape

The market is consolidated, with leading players focusing on product innovation, partnerships, and geographic expansion. Major companies include:

• Baxter
• B. Braun SE
• Fresenius Medical Care AG & Co. KGaA
• Asahi Kasei Medical Co., Ltd.
• NIPRO
• TORAY MEDICAL CO., LTD.
• Nikkiso Co., Ltd.
• Medtronic

These companies leverage strong distribution networks, advanced product portfolios, and regulatory approvals to maintain competitive advantages.

Conclusion

The global CRRT consumables market, valued at USD 912.56 million in 2025, is projected to grow to USD 984.12 million in 2026 and reach USD 1,867.84 million by 2034, at a CAGR of 8.34%. Growth is driven by rising acute kidney injury cases, increasing ICU admissions, and technological advancements in renal care solutions. Although high costs and infrastructure challenges persist, ongoing innovations and the global shift toward value-based renal care are expected to sustain long-term market expansion.

Segmentation

By Type

• Dialysates
• Replacement Solutions
• Filters
• Catheters
• Others

By Modality

• Slow Continuous Ultra Filtration (SCUF)
• Continuous Venovenous Hemofiltration (CVVH)
• Continuous Venovenous Hemodialysis (CVVHD)
• Continuous Venovenous Hemodiafiltration (CVVHDF)

By Geography

• North America (By Type, Modality, and Country)
  • U.S.
  • Canada
• Europe (By Type, Modality, and Country/Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific (By Type, Modality, and Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America (By Type, Modality, and Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, Modality, and Country/Sub-region)
  • GCC
  • South Africa
  • Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of End Stage Renal Disease, Key Countries
• 4.2. New Product Launches, By Key Players
• 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
• 4.4. Technological Advancements in Renal Replacement Therapy

5. Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Dialysates
  • 5.1.2. Replacement Solutions
  • 5.1.3. Filters
  • 5.1.4. Catheters
  • 5.1.5. Others
• 5.2. Market Analysis, Insights and Forecast - By Modality
  • 5.2.1. Slow Continuous Ultra Filtration (SCUF)
  • 5.2.2. Continuous Venovenous Hemofiltration (CVVH)
  • 5.2.3. Continuous Venovenous Hemodialysis (CVVHD)
  • 5.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
• 5.3. Market Analysis, Insights and Forecast - By Region
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Latin America
  • 5.3.5. Middle East & Africa

6. North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Dialysates
  • 6.1.2. Replacement Solutions
  • 6.1.3. Filters
  • 6.1.4. Catheters
  • 6.1.5. Others
• 6.2. Market Analysis, Insights and Forecast - By Modality
  • 6.2.1. Slow Continuous Ultra Filtration (SCUF)
  • 6.2.2. Continuous Venovenous Hemofiltration (CVVH)
  • 6.2.3. Continuous Venovenous Hemodialysis (CVVHD)
  • 6.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
• 6.3. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 6.3.1. U.K.
  • 6.3.2. Germany
  • 6.3.3. France
  • 6.3.4. Spain
  • 6.3.5. Italy
  • 6.3.6. Scandinavia
  • 6.3.7. Rest of Europe

7. Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Dialysates
  • 7.1.2. Replacement Solutions
  • 7.1.3. Filters
  • 7.1.4. Catheters
  • 7.1.5. Others
• 7.2. Market Analysis, Insights and Forecast - By Modality
  • 7.2.1. Slow Continuous Ultra Filtration (SCUF)
  • 7.2.2. Continuous Venovenous Hemofiltration (CVVH)
  • 7.2.3. Continuous Venovenous Hemodialysis (CVVHD)
  • 7.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
• 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.3.1. Japan
  • 7.3.2. China
  • 7.3.3. India
  • 7.3.4. Australia
  • 7.3.5. Southeast Asia
  • 7.3.6. Rest of Asia Pacific

8. Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Dialysates
  • 8.1.2. Replacement Solutions
  • 8.1.3. Filters
  • 8.1.4. Catheters
  • 8.1.5. Others
• 8.2. Market Analysis, Insights and Forecast - By Modality
  • 8.2.1. Slow Continuous Ultra Filtration (SCUF)
  • 8.2.2. Continuous Venovenous Hemofiltration (CVVH)
  • 8.2.3. Continuous Venovenous Hemodialysis (CVVHD)
  • 8.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
• 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.3.1. Brazil
  • 8.3.2. Mexico
  • 8.3.3. Rest of Latin America

9. Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Dialysates
  • 9.1.2. Replacement Solutions
  • 9.1.3. Filters
  • 9.1.4. Catheters
  • 9.1.5. Others
• 9.2. Market Analysis, Insights and Forecast - By Modality
  • 9.2.1. Slow Continuous Ultra Filtration (SCUF)
  • 9.2.2. Continuous Venovenous Hemofiltration (CVVH)
  • 9.2.3. Continuous Venovenous Hemodialysis (CVVHD)
  • 9.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
• 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.3.1. GCC
  • 9.3.2. South Africa
  • 9.3.3. Rest of Middle East & Africa

10. Competitive Analysis

• 10.1. Global Market Share Analysis (2025)
• 10.2. Company Profiles
  • 10.2.1. Baxter
    • 10.2.1.1. Overview
    • 10.2.1.2. Products
    • 10.2.1.3. SWOT Analysis
    • 10.2.1.4. Recent Developments
    • 10.2.1.5. Strategies
    • 10.2.1.6. Financials (Based on Availability)
  • 10.2.2. B Braun SE
    • 10.2.2.1. Overview
    • 10.2.2.2. Products
    • 10.2.2.3. SWOT Analysis
    • 10.2.2.4. Recent Developments
    • 10.2.2.5. Strategies
    • 10.2.2.6. Financials (Based on Availability)
  • 10.2.3. Fresenius Medical Care AG & Co. KGaA
    • 10.2.3.1. Overview
    • 10.2.3.2. Products
    • 10.2.3.3. SWOT Analysis
    • 10.2.3.4. Recent Developments
    • 10.2.3.5. Strategies
    • 10.2.3.6. Financials (Based on Availability)
  • 10.2.4. Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation)
    • 10.2.4.1. Overview
    • 10.2.4.2. Products
    • 10.2.4.3. SWOT Analysis
    • 10.2.4.4. Recent Developments
    • 10.2.4.5. Strategies
    • 10.2.4.6. Financials (Based on Availability)
  • 10.2.5. NIPRO
    • 10.2.5.1. Overview
    • 10.2.5.2. Products
    • 10.2.5.3. SWOT Analysis
    • 10.2.5.4. Recent Developments
    • 10.2.5.5. Strategies
    • 10.2.5.6. Financials (Based on Availability)
  • 10.2.6. TORAY MEDICAL CO, LTD. (TORAY INDUSTRIES, INC.)
    • 10.2.6.1. Overview
    • 10.2.6.2. Products
    • 10.2.6.3. SWOT Analysis
    • 10.2.6.4. Recent Developments
    • 10.2.6.5. Strategies
    • 10.2.6.6. Financials (Based on Availability)
  • 10.2.7. Nikkiso Co., Ltd.
    • 10.2.7.1. Overview
    • 10.2.7.2. Products
    • 10.2.7.3. SWOT Analysis
    • 10.2.7.4. Recent Developments
    • 10.2.7.5. Strategies
    • 10.2.7.6. Financials (Based on Availability)
  • 10.2.8. Medtronic
    • 10.2.8.1. Overview
    • 10.2.8.2. Products
    • 10.2.8.3. SWOT Analysis
    • 10.2.8.4. Recent Developments
    • 10.2.8.5. Strategies
    • 10.2.8.6. Financials (Based on Availability)
  • 10.2.9. Other Prominent Players